Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
The compositions and methods of administration described in this invention are based on indole carbazole, which causes terminal differentiation of tumor cells by exploiting a normal physiologic pathway. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Feb 2006 - 332 pages - $3,900
Jun 2006 - 434 pages - $2,495
Jan 2008 - 330 pages - $4,200
Jan 2010 - 250 pages - $3,900
Nov 2009 - 142 pages - $2,350
Jul 2011 - 96 pages - $3,835
Dec 2007 - 49 pages - $495
Nov 2010 - 189 pages - $2,350
Jan 2010 - $75
Jan 2011 - 124 pages - $1,740
Your selection
Browse By
- Therapeutic target
- Acne
- Actinic keratosis
- Alopecia
- Bacterial infection
- Burns
- Chronic idiopathic urticaria
- Cosmetic procedures
- Dermal ulcers
- Dermatitis, allergic
- Dermatitis, atopic
- Dermatological (other)
- Dermatosis
- Eczema
- Fungal infection
- Hirsutism
- Human B19 parvovirus
- Hyperkeratosis
- Ichthyosis
- Impetigo
- Insect bite
- Keloids
- Lupus
- Male pattern baldness
- Paget's disease
- Photodamage
- Pruritis
- Psoriasis
- Scleroderma
- Shingles
- Skin infection (other)
- Ulcer, diabetic
- Urticaria
- Wound healing
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us